Embecta (EMBC) reported fiscal Q4 adjusted earnings Tuesday of $0.45 per diluted share, down from $0.59 a year earlier.
Analysts polled by FactSet expected $0.36.
Revenue for the quarter ended Sept. 30 was $286.1 million, down from $281.9 million a year earlier.
Four analysts surveyed by FactSet expected $277 million
For fiscal 2025, the medical supplies company expects adjusted EPS of $2.70 to $2.90 on revenue of $1.09 billion to $1.11 billion. Analysts polled by FactSet expect non-GAAP EPS of $2.27 on revenue of $1.12 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.